middle.news
Can BlinkLab’s $5.7M Loss Fund a Breakthrough in Autism Diagnostics?
3:01am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
Can BlinkLab’s $5.7M Loss Fund a Breakthrough in Autism Diagnostics?
3:01am on Saturday 30th of August, 2025 AEST
Key Points
Revenue increased to $375,551, up 916%
Net loss widened to $5.7 million, reflecting expanded R&D and operational costs
Successful $7.66 million capital raise in May 2025
Progress in US FDA registrational trial for autism with rapid participant recruitment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Blinklab (ASX:BB1)
OPEN ARTICLE